Crocs Sues Five Below for Patent, Trademark Claims Over Dupes

Crocs and Jibbitz sued Five Below, claiming the retailer sold shoes and charms that infringe on Crocs' patents and trademarks. The lawsuit, filed in Colorado, alleges Five Below's products copy Crocs' Saru Clog and registered trade dress. Five Below has not yet responded to the allegations.

Original reporting
Published Sep 18, 2026, 9:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 19, 2026, 12:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crocs Sues Five Below for Patent, Trademark Claims Over Dupes — source image
Decision brief

The 30-second read

$FIVEBearishMed
01

Why it matters

Legal action introduces litigation risk for both companies, potentially affecting stock prices and brand perception.

02

Market read

First report of a lawsuit between two publicly traded retailers, creating short-term trading considerations.

03

What to watch

Potential for settlement or licensing agreement that could mitigate long-term effects.

Relevance 7/10Novelty 8/10Timing: Friday

Background

Crocs and its subsidiary Jibbitz sued Five Below in Colorado federal court over design patents and trademarks.

Company-level read

Ticker impact

$FIVEBearishMedium confidence
Context

Five Below is sued by Crocs for trademark and design infringement, exposing it to liability.

Expected impact

Downside pressure of 1-3% as investors assess exposure.

Evidence & confidence

Litigation could lead to damages or injunctions, affecting margins.

Market effects

May raise awareness of IP enforcement in footwear and retail sectors.

Limited to U.S. retail and consumer goods markets.

Low global impact; primarily U.S. investors.

Counterpoint

The lawsuit may be a strategic move by Crocs to deter competitors, but could be settled quickly with minimal impact.

Key entities

  • Crocs Inc.

    Footwear manufacturer filing the lawsuit.

  • Five Below Inc.

    Discount retailer accused of selling infringing products.

Related articles

$FIVEMedAI 8/10

FIVE Stock Jumps 26.9% in 3 Months: Can the Rally Continue Higher?

Five Below (FIVE) shares rose 26.9% in 3 months, driven by strong sales growth and improved earnings expectations. Comparable sales increased 14.1% in Q2, with broad-based growth across customer groups and product categories. Adjusted gross margin expanded 220 basis points to 35.6%. Management raised fiscal 2026 guidance, including net sales to $5.63-$5.71 billion and EPS to $9.83-$10.31. The rally has led to a premium valuation, requiring sustained performance to maintain momentum.

$FIVEMed

Insiders Trim Positions in Five Below Stock After 39% Run-Up

Five Below (FIVE) stock rose 39% over two months, hitting an all-time high. Insiders sold shares: Director Michael Devine sold 4,250 shares for ~$1.1M, and COO Kenneth Bull sold 1,510 shares for ~$2.6M. Q2 earnings showed 23% sales growth, 108% net income increase, and raised guidance. Analysts upgraded price targets, with 67% rating it a buy.

$FIVEHighAI 8/10

Five Below (FIVE) Q2 2027 Earnings Call Transcript

Five Below (FIVE) reported Q2 2027 net sales of $1.26B, up 22.9% YoY, with comparable sales growth of 14.1%. Adjusted EPS rose to $1.68, more than doubling from the prior year. The company opened 52 new stores, bringing the total to 2,022. Guidance for Q3 and full-year 2026 was raised, with sales expected to grow 18% and 10-12%, respectively. Management highlighted strong customer retention and plans to enter Puerto Rico in late 2027. Risks include higher fuel costs and potential tariff impacts

$FIVEHighAI 8/10

Jim Cramer Says Five Below (FIVE) is a “Buy, Buy, Buy”

Five Below (FIVE) reported Q2 net sales of $1.26B, up 22.9% YoY, with EPS of $1.68, beating estimates. The company raised its fiscal 2026 outlook but faces slowing comparable sales and tariff risks. Jim Cramer called the stock a 'buy' despite a recent price drop, citing strong earnings and management execution.